Acuvail and Eye irritation - a phase IV clinical study of FDA data

Summary:

Eye irritation is reported as a side effect among people who take Acuvail (ketorolac tromethamine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pred Forte, and have Cataract.

The phase IV clinical study analyzes which people have Eye irritation when taking Acuvail. It is created by eHealthMe based on reports of 146 people who have side effects when taking Acuvail from the FDA, and is updated regularly.

What is Acuvail?

Acuvail has active ingredients of ketorolac tromethamine. eHealthMe is studying from 147 Acuvail users. Check the latest studies of Acuvail.

What is Eye irritation?

Eye irritation is found to be associated with 1,296 drugs and 1,287 conditions by eHealthMe. Check the latest studies of Eye irritation.

On Jul, 16, 2026

146 people reported to have side effects when taking Acuvail.
Among them, 23 people (15.75%) have Eye irritation.

Among these 23 people:

How long have people been on Acuvail when they have Eye irritation? *

What is the gender of people who have Eye irritation when taking Acuvail? *

female: 86.96 %
male: 13.04 %

What is the age of people who have Eye irritation when taking Acuvail? *

What are other drugs people take besides Acuvail? *

What are other side effects people have besides Eye irritation? *

Eye Pain: 5 people, 21.74%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 3 people, 13.04%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 3 people, 13.04%
Pain: 2 people, 8.70%
Weakness: 1 person, 4.35%
Vision Blurred: 1 person, 4.35%
Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 1 person, 4.35%
Nausea (feeling of having an urge to vomit): 1 person, 4.35%
Lacrimation Increased: 1 person, 4.35%
Itching: 1 person, 4.35%

What are the existing conditions these people have? *

Eye Inflammation: 2 people, 8.70%
Cataract (clouding of the lens inside the eye): 2 people, 8.70%
Pain: 1 person, 4.35%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 4.35%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 4.35%
Macular Fibrosis (a thin sheet of scar tissue forms on top of the macula, in response to damage or injury): 1 person, 4.35%
Intraocular Pressure Increased: 1 person, 4.35%
Eye Pain: 1 person, 4.35%
Eye Disorder: 1 person, 4.35%
Dry Eyes (lack of adequate tears): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Acuvail and have Eye irritation?

- Check whether Eye irritation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acuvail:

Acuvail (147 reports)

Eye irritation treatments and more:

Eye irritation (50,674 reports)

Browse all side effects of Acuvail:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye irritation:

Eye irritation (1,296 drugs)

Browse all the conditions that are associated with Eye irritation:

Eye irritation (1,287 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine (the active ingredients of Acuvail) and Acuvail (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.